Today marks year since FDAs accelerated approval of a drug to treat Duchenne muscular dystrophy, with remarkable success for Hoosier Jordan McLinn. Now its time to take the next step to make therapies available to those with life-threatening diseases: Promising Pathway Act. https://t.co/HJrG1OLujX